129 related articles for article (PubMed ID: 37003144)
1. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
[TBL] [Abstract][Full Text] [Related]
5. The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E
Sun G; Fuller H; Fenton H; Race AD; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Int J Cancer; 2024 Mar; 154(5):873-885. PubMed ID: 37855394
[TBL] [Abstract][Full Text] [Related]
6. Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.
Downing A; Fenton H; Nickerson C; Loadman PM; Williams EA; Rees CJ; Brown LC; Morris EJA; Hull MA
Aliment Pharmacol Ther; 2023 Sep; 58(6):562-572. PubMed ID: 37518954
[TBL] [Abstract][Full Text] [Related]
7. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
8. APOE Genotype Modifies the Plasma Oxylipin Response to Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Individuals.
Saleh RNM; West AL; Ostermann AI; Schebb NH; Calder PC; Minihane AM
Front Nutr; 2021; 8():723813. PubMed ID: 34604280
[TBL] [Abstract][Full Text] [Related]
9. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective ultra-high performance liquid chromatography-tandem mass spectrometry method based on sub-2µm particle polysaccharide column for chiral separation of oxylipins and its application for the analysis of autoxidized fatty acids and platelet releasates.
Cebo M; Fu X; Gawaz M; Chatterjee M; Lämmerhofer M
J Chromatogr A; 2020 Aug; 1624():461206. PubMed ID: 32540064
[TBL] [Abstract][Full Text] [Related]
11. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.
Lamon-Fava S; So J; Mischoulon D; Ziegler TR; Dunlop BW; Kinkead B; Schettler PJ; Nierenberg AA; Felger JC; Maddipati KR; Fava M; Rapaport MH
Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102219. PubMed ID: 33316626
[TBL] [Abstract][Full Text] [Related]
12. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
13. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH
Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis.
West NJ; Clark SK; Phillips RK; Hutchinson JM; Leicester RJ; Belluzzi A; Hull MA
Gut; 2010 Jul; 59(7):918-25. PubMed ID: 20348368
[TBL] [Abstract][Full Text] [Related]
15. Chiral chromatography-tandem mass spectrometry applied to the determination of pro-resolving lipid mediators.
Homann J; Lehmann C; Kahnt AS; Steinhilber D; Parnham MJ; Geisslinger G; Ferreirós N
J Chromatogr A; 2014 Sep; 1360():150-63. PubMed ID: 25124229
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipoxin A
Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
[TBL] [Abstract][Full Text] [Related]
17. Collection and Storage of Human Plasma for Measurement of Oxylipins.
Polinski KJ; Armstrong M; Manke J; Seifert J; Crume T; Yang F; Clare-Salzler M; Holers VM; Reisdorph N; Norris JM
Metabolites; 2021 Feb; 11(3):. PubMed ID: 33652624
[TBL] [Abstract][Full Text] [Related]
18. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M; Sanchez-Niño MD; Ortiz A; García de Vinuesa S; Quiroga B; Bernis C; Morales E; Fernández-Juarez G; de Sequera P; Verdalles U; Verde E; Luño J
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():8-13. PubMed ID: 28987723
[TBL] [Abstract][Full Text] [Related]
19. Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood.
Schuchardt JP; Ostermann AI; Stork L; Fritzsch S; Kohrs H; Greupner T; Hahn A; Schebb NH
Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():76-87. PubMed ID: 28651702
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
